Article Information
History
- February 12, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 12, 2021 - 07:20).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Partho Sen1,2,*,
- Olivier Govaere3,
- Tim Sinioja4,
- Aidan McGlinchey1,
- Dawei Geng4,
- Vlad Ratziu5,
- Elisabetta Bugianesi6,
- Jörn M. Schattenberg7,
- Antonio Vidal-Puig8,
- Michael Allison9,
- Simon Cockell3,
- Ann K. Daly3,
- Tuulia Hyötyläinen4,
- Quentin M. Anstee3,10,*,§ and
- Matej Orešič1,2,*,§
- 1School of Medical Sciences, Örebro University, 70281 Örebro, Sweden
- 2Turku Bioscience, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland
- 3Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
- 4Department of Chemistry, Örebro University, 70281 Örebro, Sweden
- 5Assistance Publique-Hôpitaux de Paris, hôpital Beaujon, University Paris-Diderot, Paris, France
- 6Department of Medical Sciences, Division of Gastro-Hepatology, A.O. Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
- 7Metabolic Liver Research Programm, Department of Medicine, University Hospital Mainz, Mainz, Germany
- 8University of Cambridge Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
- 9Liver Unit, Department of Medicine, Cambridge Biomedical Research Centre, Cambridge University NHS Foundation Trust, United Kingdom
- 10Newcastle NIHR Biomedical Research Center, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- ↵*Correspondence: quentin.anstee{at}newcastle.ac.uk, matej.oresic{at}oru.se
Posted February 12, 2021.
Quantitative genome-scale analysis of human liver reveals dysregulation of glycosphingolipid pathways in progressive nonalcoholic fatty liver disease
